Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER THERAPY

Biomarker approach harnessed in trials of personalized medicine for bladder cancer

A multi-arm clinical trial reports results of testing a strategy for the treatment of bladder cancer that uses standard immunotherapy plus biomarker assessment and targeted therapies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Clinical-trial designs to test treatments for bladder cancer.

References

  1. Powles, T. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01317-6 (2021).

  2. Powles, T. et al. JAMA Oncol. 3, e172411 (2017).

    Article  Google Scholar 

  3. Loriot, Y. et al. N. Engl. J. Med. 381, 338–348 (2019).

    Article  CAS  Google Scholar 

  4. Robinson, B. D. et al. Nat. Commun. 10, 1–11 (2019).

    Article  CAS  Google Scholar 

  5. Siefker-Radtke, A. O. et al. J. Clin. Oncol. 37, 4511–4511 (2019).

    Article  Google Scholar 

  6. de Bono, J. et al. N. Engl. J. Med. 382, 2091–2102 (2020).

    Article  Google Scholar 

  7. Jette, N. R. et al. Cancers (Basel) 12, 687 (2020).

    Article  CAS  Google Scholar 

  8. Milowsky, M. I. et al. BJU Int. 112, 462–470 (2013).

    Article  CAS  Google Scholar 

  9. Iyer, G. et al. Science 338, 221 (2012).

    Article  CAS  Google Scholar 

  10. Wan, X., Harkavy, B., Shen, N., Grohar, P. & Helman, L. J. Oncogene 26, 1932–1940 (2007).

    Article  CAS  Google Scholar 

  11. Powles, T. et al. Eur. Urol. 69, 450–456 (2016).

    Article  CAS  Google Scholar 

  12. Sargent, D. J., Conley, B. A., Allegra, C. & Collette, L. J. Clin. Oncol. 23, 2020–2027 (2005).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sumanta K. Pal.

Ethics declarations

Competing interests

N. D. reports consulting for Vivreon Bioscience. S.K.P. reports consulting for Genentech, Aveo, Eisai, Roche, Pfizer, Novartis, Exelixis, Ipsen, BMS and Astellas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dizman, N., Meza, L. & Pal, S.K. Biomarker approach harnessed in trials of personalized medicine for bladder cancer. Nat Med 27, 761–763 (2021). https://doi.org/10.1038/s41591-021-01300-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-021-01300-1

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer